Tip:
Highlight text to annotate it
X
[MUSIC]
Autoimmune diseases are extremely common in the, in the population.
As a group of diseases the can affect any organ, any tissue.
They often affect people in the prime of their lives that diseases can
cause significant mobility, then some of them can cause mortality.
So as a problem in in the world or immunity
is, is a great one which needs understanding a solution.
Johns Hopkins is a long history in studying autoimmune diseases.
Some of the early founders of
Hopkins were interested and noticed autoimmune diseases.
So, it is really in in our DNA to study these diseases.
The approach I think that Hopkins takes which has been
relatively unique, is to, follow patients in the context of
clinical care and to partner with them, in discovery, to try and
understand the causes mechanisms, of the auto-immune diseases.
We do it across the spectrum.
The environment, is really incredibly interactive.
Synergistic one, people who are interested in the autoimmunomatic
diseases, diseases like lupus and myositis, and scleroderma, interact with
people who are interested in autoimmunity in the kidney,
autoimmunity in the nervous system autoimmunity in the endocrine system.
Generating a lot of collaboration, synergy.
the, the institution has really made great strides in understanding the mechanisms
of, of autoimmunity, particularly the relationship
of autoimmunity infections cancers, and so on.
I would say that, that we are in a golden age of studying autoimmunity the tools for
dissecting the mechanisms of complex human disorders have changed dramatically
over the last decade, and autoimmunity finally is in this phase when really big
strides are gonna be made in terms
of understanding, preventing in curing these diseases.
[MUSIC]
[BLANK_AUDIO]